AIG
WHWK

American International Group’s Whitehawk Therapeutics WHWK Stock Holding History

American International Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,993
Closed -$18.7K – 2857
2024
Q1 		$18.7K Sell
7,993
-69
-0.9% -$133 ﹤0.01% 2938
2023
Q4 		$16.3K Sell
8,062
-32
-0.4% -$134 ﹤0.01% 2985
2023
Q3 		$39.2K Buy
8,094
+288
+4% +$1.67K ﹤0.01% 2881
2023
Q2 		$53.4K Buy
7,806
+817
+12% +$6.35K ﹤0.01% 2868
2023
Q1 		$50.6K Buy
6,989
+140
+2% +$1.5K ﹤0.01% 2715
2022
Q4 		$87.9K Sell
6,849
-25
-0.4% -$326 ﹤0.01% 2571
2022
Q3 		$97K Buy
6,874
+97
+1% +$1.27K ﹤0.01% 2578
2022
Q2 		$83K Buy
+6,777
New +$101K ﹤0.01% 2697

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's WHWK Position: Q2 2024 in Review

American International Group sold out of Whitehawk Therapeutics (WHWK) in Q2 2024, closing a stake of 7,993 shares — an estimated $18.7K sold.

American International Group first reported a position in WHWK in Q2 2022 and held it in 8 quarters. The position peaked at $97K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q2 2024.

  • American International Group reported no remaining Whitehawk Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 7,993 Whitehawk Therapeutics shares in Q2 2024, an estimated $18.7K.
  • American International Group first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 8 quarters.
  • American International Group's Whitehawk Therapeutics position peaked at $97K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.